Clinical Trials

We are pleased to provide you with a summary of some of the most exciting work we are currently pursuing that we closer to better treatments for cancer:


The Felsher laboratory has ongoing clinical trials to identify prognostic protein biomarkers and gene signatures for many types of human cancer including: lymphoma, liver cancer, renal cancer and lung cancer.


The Felsher laboratory develops technologies, diagnostics and therapeutics. We have developed the Nanoimmunoassay (NIA) to analyze very small amounts of tumor and/or blood to develop a powerful new approach for the diagnosis of cancer.

Taking the measure of mouse and human to identify oncoproteins through nano-fluidic capillaries.

To learn more about the Felsher Laboratory online:

Recent Press Releases

Translational Research and Applied Medicine Program

Dr. Felsher is the founding Director of theĀ Translational Research and Applied Medicine (TRAM) Program in the Department of Medicine

If you are interested in supporting our clinical research activities please consider sending a gift to:

Dr. Dean W. Felsher, c/o Phyllis Bussey
Division of Oncology, 269 Campus Drive
Stanford, CAA 94305-5151.
Please specify on the check that the funds are to go to the Felsher Gift Fund